[1]
Bigge, S. 2026. Low-dose oral tranexamic acid for melasma: a narrative review and practical thromboembolic risk assessment framework. International Journal of Research in Dermatology. (Jul. 2026). DOI:https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20262368.